Surgery for treating large idiopathic macular holes
Official title: Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT06063005 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new surgical method for treating large macular holes to see if it helps people see better and improves their quality of life compared to the standard surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years to 70 Years |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT06063005 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with idiopathic macular holes measuring between 500 and 900 µm in diameter and who meet specific ocular criteria.
✕Probably not a fit
Patients with other retinal disorders or high myopia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the effectiveness of a new surgical technique involving the translocation of the internal limiting membrane (ILM) flap compared to traditional surgery for large idiopathic macular holes. It is a prospective randomized controlled trial designed to assess improvements in visual function, anatomical healing of the retina, and overall quality of life for patients. Participants will undergo either the new surgical approach or the conventional method, with outcomes monitored through follow-up assessments.
Why it matters
Potential benefit: If successful, this approach could significantly improve visual outcomes and quality of life for patients with large idiopathic macular holes.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving surgical outcomes for macular holes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who can understand the purpose of this clinical trial, volunteer to participate, sign an informed consent form, and can complete the postoperative follow-up on time. * Participants diagnosed with idiopathic macular hole (IMH). * Based on OCT scans, the minimum horizontal diameter of the macular hole is \>500 and \<900 µm. * Participants with an axial length \<26.0mm and a myopic degree lower than 6D. * For participants with bilateral macular holes, the eye with a larger hole diameter will be included. Exclusion Criteria: * Patients with the following retinal disorders: age-related macular degeneration, epi-macular membrane neovascularization, non-macular retinal tears, lesions of the retinal pigment epithelium and choroid, inherited or degenerative retinal diseases, optic neuropathies, retinal vascular diseases; patients with large macular holes accompanied by retinal detachment; * Patients with high myopia (axial length ≥ 26.0mm and myopia exceeding 6D); * Patients with a history of ocular trauma or retinal laser treatment; * Patients with glaucoma, ocular infections, inflammations, tumors, corneal diseases, or amblyopia; * Patients with contraindications to vitrectomy; * Patients with severe or unstable systemic diseases; * Patients with a fasting blood glucose level ≥ 9mmol/L before surgery; * Patients who participated in other clinical trials involving drugs or medical devices within 30 days prior to screening; * Patients with a history of intraocular surgery within 3 months prior to screening; * Patients with reduced visual function or vision in the contralateral eye as determined by the investigator; * Patients who are not considered suitable for enrollment by the investigator for other reasons.
Where it's running
-
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Study contacts
- Study coordinator: Peiquan Zhao, Dr.
- Email: zhaopeiquan@xinhuamed.com.cn
- Phone: 0086 13311620396
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ten modern techniques for full-thickness macular hole repair compared
We are testing ten different surgical approaches to fix full-thickness macular holes in adults to see which method closes the hole best and gives the best vision.
-
Comparing surgery times for UNITY® VCS and CONSTELLATION® Vision System
This study will see if the UNITY® VCS or the CONSTELLATION® Vision System leads to shorter combined cataract and vitrectomy (phacovitrectomy) surgery times for adults planned for 25‑gauge procedures.
-
Decellularized amniotic membrane hydrogel vs inverted ILM flap for large macular holes
This trial tests whether injecting decellularized human amniotic membrane hydrogel can close large macular holes as effectively as the inverted ILM flap technique after vitrectomy.
-
Repositioning the peeled inner limiting membrane to treat macular holes
This study is testing a new surgery that moves a part of the eye to help close macular holes in older patients, instead of removing it like usual.
-
Treatment of small macular holes using air
This study tests whether using air instead of gas during surgery can help close small macular holes in the eyes for patients who have had them for less than a year.
-
Comparing face-down positioning durations after macular hole surgery
This study is testing whether sitting face-down for 3 days or 7 days after macular hole surgery helps people heal better and see clearly.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.